written by reader Is Biogenomics’ Saphyr optical genome mapping (OGM) system for real? Stock is soaring in this Fintech field.

By donsasser, January 25, 2021

Been eyeballing this small company and they Saphyr optical genome mapping (OGM) system for the last couple of months. It’s gone from about 3.60 to over $12.00 today and boy am I sorry I didn’t
follow my instincts when I first started reading about this company. They changed their (Losing) business model from selling the uber expensive Syphyr OGM at a rough cost of 200 g to now selling subscriptions and deriving repeat income from clients that love they equipment but don’t want to put out 200G. I’m bullish on this fintech company and was wondering if anybody out there has any thoughts. Love to hear from you guys! Their stock has jumped from 3.60 to over 12.50 in the last 30 days.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.